Metabolomics for early detection of drug-induced kidney injury: review of the current status.
about
Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicityMetabolic profiling of the protozoan parasite Entamoeba invadens revealed activation of unpredicted pathway during encystationImplementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI)Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.Academic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery NetworkActivation of the calcium-sensing receptor before renal ischemia/reperfusion exacerbates kidney injury.Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity.Marking renal injury: can we move beyond serum creatinine?Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo.Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers.Ablation of the locus coeruleus increases oxidative stress in tg-2576 transgenic but not wild-type mice.Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats.Bioanalysis: the best of 2009.Metabolomics of World Trade Center-Lung Injury: a machine learning approach
P2860
Q28087473-8324086D-7460-491A-B55A-DD9582DC6DF2Q28483924-7105B05C-7F42-40D0-8E61-AF504637446FQ30415871-E16B6F57-0B66-4C2F-AB5E-86C60598E77EQ34155281-33D944DB-1886-4CE8-A1E9-5784AA9ED7D8Q34357303-277DD35A-48CF-479D-A431-8F34EE3A419AQ35137812-7FDE5B5F-0D26-491C-A397-38B1F0D5B29FQ35639184-623B5D29-90E0-40E3-A9C8-9AC099C85892Q35841388-B7BBA9E6-73DB-4EE6-9102-49B460F819E4Q35907785-1CF54B47-DA18-442F-AEE8-2A56C9FAFC0DQ36054738-6F6E7B54-2C8B-404F-B522-17B0F3111C96Q37168478-E7000346-6847-436E-AAA4-884846F4823CQ41988079-21404354-D969-44D3-B5A3-0D6BD15DBDE9Q44559241-E9C9EE99-7321-4EA1-9341-C88C64D1BD49Q48303993-084A6744-964F-4791-BD21-6BFF270FC260Q58767056-E8F40AC9-C48C-496F-9DD9-87E1266E1997
P2860
Metabolomics for early detection of drug-induced kidney injury: review of the current status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolomics for early detecti ...... review of the current status.
@en
Metabolomics for early detecti ...... review of the current status.
@nl
type
label
Metabolomics for early detecti ...... review of the current status.
@en
Metabolomics for early detecti ...... review of the current status.
@nl
prefLabel
Metabolomics for early detecti ...... review of the current status.
@en
Metabolomics for early detecti ...... review of the current status.
@nl
P2093
P2860
P356
P1433
P1476
Metabolomics for early detecti ...... review of the current status.
@en
P2093
Donald J Rose
Douglas P Lee
Edward D Karoly
Kay A Lawton
Kurt J Boudonck
Paula J Lapinskas
P2860
P304
P356
10.4155/BIO.09.142
P577
2009-12-01T00:00:00Z